Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor.

Source:http://linkedlifedata.com/resource/pubmed/id/9751783

Proc. Natl. Acad. Sci. U.S.A. 1998 Sep 29 95 20 12022-7

Download in:

View as

Triples

General Info

PMID
9751783